One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The power of resilience
doi : 10.1016/S2213-8587(22)00010-9
Volume 10, Issue 2, February 2022, Page 85
How do clinicians integrate oral octreotide into their treatment plan for acromegaly?
Maya BLodisha
Understanding decreasing mortality in people with diabetes
JenniferManne-GoehleraDavidFloodb
The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand still
Aaron WMichelsaMaria JRedondobMark AAtkinsonc
Nutrition-related health taxes: setting expectations
J JaimeMirandaabcdAnne-MarieThoweMarÃa KathiaCárdenasaCamilaCorvalánfTonatiuhBarrientos-GutiérrezgJay SKaufmanh
Comparison of mortality in people with type 1 and type 2 diabetes by age of diagnosis: an incident population-based study in England and Wales
NaomiHolmanaSarah HWildbEdward WGreggcJonathanValabhjidefNaveedSattaraKamleshKhuntiag
Dapagliflozin in patients with COVID-19: mind the kidneys
ThiagoReisabMarliesOstermanncAlexanderZarbockdJohn AKellumeClaudioRoncofg
Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply
Mikhail NKosiborodabcRussellEsterlinedJanOscarssoneSamvel BGasparyaneRemo H MFurtadofgSubodhVermahiOtavioBerwangerf
Money matters in the food choices we makePriya Fielding Singh, How the Other Half Eats: The Untold Story of Food and Inequality in America, Little, Brown & Company (2021), p. 352, £20·00, ISBN: 9780316427265
TalhaBurki
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial
ProfMariaFleseriuMDaAlexanderDrevalMDbProfIrinaBondarDMSccProfGulnarVagapovaMDdProfDjuroMacutMDeYulia GPokramovichMDbProfMark EMolitchMDfNinaLeonovaMDgProfGeraldRaverotMDhProfElenaGrinevaMDiYury EPoteshkinMDjYossiGilgun-SherkiPhDkWilliam HLudlamMDlGaryPatouMDkAsiHavivDMDkProfMurray BGordonMDmProfNienke RBiermaszMDnProfShlomoMelmedMBChBoProfChristian JStrasburgerp
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data
ProfDianna JMaglianoPhDabLeiChenPhDaBendixCarstensenMSc(Stat)cProfEdward WGreggPhDdMeda EPavkovMDeAgusSalimPhDafLinda JAndesPhDeProfRanBalicerMDgMartaBavieraPharmDhProfJuliana C NChanMDiYiling JChengPhDeHeleneGardinerMPHjHanne LGulsethMDkProfRomualdasGureviciusMDlmProfKyoung HwaHaPhDnGyörgyJermendyDScoProfDae JungKimMDnZoltánKissMDp…ProfJonathan EShawMDabac
The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality
ProfRachel ENealePhDabCatherineBaxterBAaBriony DuarteRomeroBAaDonald S AMcLeodPhDacProfDallas REnglishPhDdeProfBruce KArmstrongD PhilfgProfPeter REbelingMDhGunterHartelPhDaProfMichael GKimlinPhDiRachelO'ConnellPhDjJolieke Cvan der PolsPhDkProfAlison JVennPhDlProfPenelope MWebbD PhilabProfDavid CWhitemanPhDabMaryWaterhousePhDa
Subclinical hypothyroidism in older individuals
ProfBernadetteBiondiMDaProfAnne RCappolaMD ScMb
Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia
ProfGary FLewisMDabProfRobert AHegeleMDc
